A Randomised, Controlled, Parallel-Group, Open-Label Study to Evaluate Different Dosing Regimens of Rabeprazole in Controlling Nocturnal Heartburn Symptoms in Patients With Gastroesophageal Reflux Disease
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2010
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux; Heartburn
- Focus Therapeutic Use
- Sponsors Janssen Inc
- 31 Mar 2010 Actual number of patients (48) added as reported by ClinicalTrials.gov record.
- 30 Nov 2007 New trial record.